Nkarta, Inc. (NKTX) Financials

NKTX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 405.9 million 109.0 million
2023-06-30 429.0 million 111.1 million
2023-03-31 458.2 million 111.5 million
2022-12-31 472.9 million 100.7 million

NKTX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -26.5 million 4.3 million
2023-06-30 -32.1 million 4.7 million
2023-03-31 -25.6 million 4.7 million
2022-12-31 -42.4 million 4.5 million

NKTX Net Income

No data available :(

NKTX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 275.6 million - 89.5 million
2023-06-30 280.8 million - 90.5 million
2023-03-31 323.3 million - 91.3 million
2022-12-31 354.9 million - 82.9 million

NKTX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 49.1 million
2023-06-30 49.0 million
2023-03-31 48.9 million
2022-12-31 48.8 million

NKTX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 6.2 million 22.2 million 7.1 million -
2023-06-30 10.3 million 25.1 million 11.7 million -
2023-03-31 4.8 million 26.1 million 8.2 million -
2022-12-31 35.0 million 26.8 million 8.1 million -

NKTX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 2.5 million
2023-06-30 - 1.4 million
2023-03-31 - 1.3 million
2022-12-31 - 1.4 million

NKTX

Price: $7.10

52 week price:
1.28
16.24

Earnings Per Share: -2.40 USD

P/E Ratio: -4.16

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 296100

Market Capitalization: 615.5 million

Links: